5. Hepatitis B
• Causative agent:
• A hepadnavirus; hepatitis B virus
• Mode of transmission:
• Body fluids,
• Transfusion of contaminated blood,
• Use of contaminated needle,
• To fetus via mother
• Incubation period:
• Average 60–90 days
6. Hepatitis B
• Period of communicability/ when/how long disease contagious
• End of incubation time and during acute stage
• Clinical manifestations
• Anorexia,
• Abdominal discomfort,
• Nausea,
• Vomiting,
• Jaundice
• Prevention/ immunization/immunity
• Use of standard precautions
• Vaccine for hepatitis B
• After exposure— HBIG (hepatitis B immune globulin)
7. Hepatitis B
• Treatment/nursing care
• Rest,
• Nutrition with good caloric intake
• Complications
• Possibly fatal,
• Liver problems,
• In some cases possibly leading to chronic hepatitis
9. Diphtheria
• Causative agent:
• Corynebacterium diphtheriae
• Mode of transmission:
• Droplet,
• Direct contact with infected person,
• Carrier,
• Contaminated article
• Incubation period:
• 2–7 days
10. Diphtheria
• Period of communicability/ when/how long disease contagious
• 2–4 weeks in untreated person
• 1–2 days with antibiotic therapy
• Clinical manifestations
• Mucous membranes of nose and throat covered by gray membrane;
• Purulent nasal discharge;
• Brassy cough;
• Toxin from organism passes through bloodstream to heart and nervous system
• Prevention/ immunization/immunity
• Active immunity from diphtheria toxin in dtap vaccine
• Passive immunity with diphtheria antitoxin
11. Diphtheria
• Treatment/nursing care
• Strict droplet precautions;
• Intravenous antitoxin and
antibiotics;
• Bed rest;
• Liquid to soft diet;
• Analgesics for throat pain;
• Immunization for nonimmunized
contacts
• Complications
• Neuritis,
• Carditis,
• Heart failure,
• Respiratory failure
13. Tetanus
• Causative agent:
• Clostridium tetani
• Mode of transmission:
• Direct or indirect contamination of a closed wound
• Incubation period:
• 3–21 days
14. Tetanus
• Period of communicability/ when/how long disease contagious
• Non
• Clinical manifestations
• Stiffness of neck and jaw,
• Muscle rigidity of trunk and extremities,
• Arched back,
• Abdominal muscle stiffness,
• Unusual facial appearance,
• Pain due to muscle spasms
• Prevention/ immunization/immunity
• Active immunity from tetanus toxoid in DTaP vaccine
15. Tetanus
• Treatment/nursing care
• Quiet room,
• Wound cleaning and débridement,
• Penicillin G or erythromycin,
• Muscle relaxants
• Complications
• Serious,Fatal if untreated,
• Possible respiratory complications
17. Pertussis (whooping cough)
• Causative agent:
• Bordetella pertussis
• Mode of transmission:
• Droplet,
• Direct contact with respiratory discharges
• Incubation period:
• 5–21 days
18. Pertussis (whooping cough)
• Period of communicability/ when/how long disease contagious
• About 4–6 weeks, greatest in respiratory stage
• Clinical manifestations
• Begins with mild upper respiratory symptoms;
• In 2nd week progresses to severe paroxysmal cough with inspiratory whoop,
• Sometimes followed by vomiting;
• Especially dangerous for young infants, may last 4–6 week
19. Pertussis (whooping cough)
• Prevention/ immunization/immunity
• Active immunity from pertussis vaccine in DTaP vaccine; disease gives natural
immunity
• Treatment/nursing care
• Bed rest;
• Infants hospitalized;
• Oxygen therapy possible,
• Observation for airway obstruction;
• Provision of high humidity;
• Protection from secondary infections,
• Increased fluid intake;
• Refeeding if vomiting occurs
20. Pertussis (whooping cough)
• Complications
• Pneumonia (can cause death of infant);
• Otitis media;
• Hemorrhage;
• Convulsions
22. Haemophilus influenzae type B
• Causative agent:
• Coccobacilli H. Influenzae bacteria
• Mode of transmission:
• Droplet,
• Discharge from nose and throat
• Incubation period:
• 2–4 days
23. Haemophilus influenzae type B
• Period of communicability/ when/how long disease contagious
• As long as organisms are present;
• Noncommunicable after antibiotic therapy for 24–48 hours
• Clinical manifestations
• Fever,
• Vomiting,
• Lethargy,
• Meningeal irritation with bulging fontanel or stiff neck and back,
• Stupor,
• Coma
24. Haemophilus influenzae type B
• Prevention/ immunization/immunity
• Vaccine haemophilus influenzae type b (HIB)
• Treatment/nursing care
• Antibiotics
• Complications
• Meningitis,
• Epiglottitis,
• Pneumonia
26. Poliomyelitis (infantile paralysis)
• Causative agent:
• Poliovirus
• Mode of transmission:
• Direct and indirect contact, fecal-oral route
• Incubation period:
• 7–14 days
27. Poliomyelitis (infantile paralysis)
• Period of communicability/ when/how long disease contagious
• Greatest just before onset and just after onset of symptoms,
• When virus is present in throat and feces,
• 1–6 weeks
• Clinical manifestations
• Fever,
• Headache,
• Nausea,
• Vomiting,
• Abdominal pain;
• Stiff neck,
• Pain, and
• Tenderness in lower extremities that proceeds to paralysis
28. Poliomyelitis (infantile paralysis)
• Prevention/ immunization/immunity
• Inactivated polio vaccine (IPV) disease causes active immunity against specific strain
• Treatment/nursing care
• Bed rest;
• Moist hot packs to extremities;
• Range-of motion exercises;
• Supportive care;
• Long-term ventilation if respiratory muscles involved
• Complications
• Permanent paralysis;
• Respiratory arrest
30. Rubeola (measles)
• Causative agent:
• measles virus
• Mode of transmission:
• Direct or indirect contact with droplets, nasal, and throat secretions
• Incubation period: 10–12 days
31. Rubeola (measles)
• Period of communicability/ when/how long disease contagious
• 5th incubation day through first few days after rash erupts
• Clinical manifestations
• High fever,
• Sore throat,
• Coryza (runny nose),
• Cough,
• Enlarged lymph nodes (head and neck),
• Koplik spots (small red spots with bluewhite centers on oral mucosa, specific to
rubeola),
• Conjunctivitis,
• Photophobia,
• Maculopapular rash starts at hairline and spreads to entire body
32.
33. Rubeola (measles)
• Prevention/ immunization/immunity
• Attenuated live vaccine (part of MMR vaccine)
• Disease gives lasting natural immunity
• Treatment/nursing care
• Antipyretics,
• Comfort measures for rash including
• Tepid baths, soothing lotion,
• Maintenance of dry skin;
• Dimly lighted room for comfort,
• Fluids
36. Parotitis (mumps)
• Causative agent:
• Paramyxovirus
• Mode of transmission:
• Airborne,
• Droplet,
• Direct contact with saliva of infected person
• Incubation period:
• 14–21 days
37. Parotitis (mumps)
• Period of communicability/ when/how long disease contagious
• Shortly before swelling appears until after it disappears
• Clinical manifestations
• Parotid glands swollen, unilaterally or bilaterally;
• May have fever,
• Headache,
• Malaise, and
• Complain of earache before swelling appears;
• Angle of jaw obliterated on affected side
38. Parotitis (mumps)
• Prevention/ immunization/immunity
• Attenuated live mumps vaccine (part of MMR vaccine)
• Disease gives natural immunity
• Treatment/nursing care
• Liquids and soft foods because chewing is painful;
• Avoidance of sour foods, which cause discomfort;
• Analgesics for pain;
• Antipyretics for fever;
• Local compresses of heat or cold
39. Parotitis (mumps)
• Complications
• In males past puberty orchitis (inflammation of the testes);
• Meninoencephalitis;
• Possible severe hearing impairment (rare).
41. Rubella (German measles)
• Causative agent:
• Rubella virus
• Mode of transmission:
• Direct or indirect contact with droplets, nasopharyngeal secretions
• Incubation period:
• 14–21 days
42. Rubella (German measles)
• Period of communicability/ when/how long disease contagious
• 5–7 days before until about 5 days after rash appears
• Clinical manifestations
• Low-grade fever;
• Headache,
• Malaise,
• Anorexia,
• Sore throat,
• Lymph glands of neck and head enlarged;
• Pink-red rash begins on face,
• Spreads downward, disappears in 3 days,
• May have joint pain
43. Rubella (German measles)
• Prevention/ immunization/immunity
• Attenuated live vaccine (part of MMR vaccine)
• Disease gives lasting natural immunity
• Immune serum globulin may be given to pregnant women
• Treatment/nursing care
• Comfort measures for rash,
• Antipyretics for fever and joint pain
• Complications
• Severe birth defects if mother is exposed and nonimmunized (especially in
1st trimester)
45. Varicella(chickenpox)
• Causative agent:
• Varicella zoster virus
• Mode of transmission:
• airborne, direct or indirect contact with saliva or uncrusted vesicles
• Incubation period:
• 10–21 days
• Period of communicability
• 1 day before rash appears to about 5–6 days after it appears (until all vesicles
crusted)
46. Varicella(chickenpox)
• Clinical manifestations
• Prodromal stage:
• Slight fever,
• Malaise, and anorexia for first 24 hours;
• Rash highly pruritic; begins as macule, rapidly progresses to papule and then
vesicle (surrounded by erythematous base; becomes umbilicated and cloudy;
breaks easily and forms crusts);
• All three stages (papule, vesicle, crust) present in varying degrees at one time
47. • Clinical manifestations
• Distribution: Centripetal, spreading to face and proximal extremities but
sparse on distal limbs and less on areas not exposed to heat (i.e., from clothing
or sun)
• Constitutional signs and symptoms: Elevated temperature from
lymphadenopathy, irritability from pruritus
48.
49. Varicella(chickenpox)
• Prevention/ immunization/immunity
• Attenuated live varicella virus vaccine gives active immunity
• Disease causes lasting natural immunity; may reactivate in adult as herpes zoster
• Treatment/nursing care
• Antihistamines, soothing baths and lotions to reduce itching;
• Prevention of scratching with short fingernails or use of mittens;
• Acyclovir to shorten the course of the disease; no aspirin should be given
• Complications
• Reye syndrome possible if child has had aspirin during illness;
• Secondary infection of lesions if scratched;
• Pneumonia, Encephalitis
50. Hepatitis A
• Causative agent:
• A picornavirus; hepatitis A virus
• Mode of transmission:
• Ingestion of fecal contaminated food or water or contaminated surfaces
• Incubation period:
• Average 25–30 days
• Period of communicability
• Highest during 2 weeks before onset of symptoms
52. Hepatitis A
• Prevention/ immunization/immunity
• Good handwashing, sanitary disposal of feces
• Vaccine for hepatitis A
• After exposure— immune globulin
• Treatment/nursing care
• Enteric precautions, rest, nutritious diet
54. Erythema infectiosum (fifth disease)
• Causative agent:
• Human parvovirus B19
• Mode of transmission:
• droplet, contact with respiratory secretions
• Incubation period:
• 6–14 days
• Period of communicability
• Uncertain, child may return to school when rash appears, no longer infectious
at that point
55. Erythema infectiosum
• Clinical manifestations
• Fever,
• Headache,
• Malaise;
• A week later, red rash appears on face,
called a “slapped face” rash;
• Rash appears on extremities, then on
trunk;
• Rash can reappear with heat, sunlight,
cold
56. Erythema infectiosum
• Prevention/ immunization/immunity
• No immunity
• Treatment/nursing care
• Supportive treatment with antipyretics, analgesics,
• Droplet precautions (when hospitalized)
• Complications
• Arthritis possible;
• dangerous for fetus (keep infected child away from pregnant women)
58. Roseola (exanthema subitum)
• Causative agent:
• Human herpesvirus type 6
• Mode of transmission:
• Unknown
• Incubation period:
• About 10 days
• Period of communicability
• During febrile period
59. Roseola (exanthema subitum)
• Clinical manifestations
• High fever;
• irritability;
• anorexia;
• lymph nodes enlarged;
• decreased WBC;
• rash appears just after sharp decline
in temperature;
• rash is rose-pink, mostly on trunk,
lasts 1–2 days
60. Roseola (exanthema subitum)
• Prevention/ immunization/immunity
• Contracting disease gives lasting immunity
• Treatment/nursing care
• Symptomatic for rash and fever;
• Standard precautions (if hospitalized)
62. Lyme disease
• Causative agent:
• Borrelia burgdorferi
• Mode of transmission:
• deer tick bite
• Incubation period:
• 3–30 days
• Period of communicability
• Not communicable from one person to another
63. Lyme disease
• Clinical manifestations
• Starts as a red papule that spreads and becomes a large, round red
ring;
• Fever;
• Malaise;
• Headache;
• Mild neck stiffness with rash;
• Leads to systemic symptoms and chronic problems
64. Lyme disease
• Prevention/ immunization/immunity
• Avoid tick infected areas;
• inspect skin after being in wooded areas
• Active immunity from Lyme disease vaccine
• Treatment/nursing care
• Antibiotics
• Complications
• Cardiac, musculoskeletal, and neurologic involvement
66. Scarlet Fever
• Causative agent:
• Beta-hemolytic streptococci group A
• Mode of transmission:
• direct contact, droplet
• Incubation period:
• 2–5 days
• Period of communicability
• During acute respiratory phase, 1–7 days
67. Scarlet Fever
• Clinical manifestations
• Begins abruptly;
• Fever; sore throat; headache; chills;
malaise;
• Red rash on skin and mucous
membranes;
• Tonsils inflamed; enlarged; white
exudate;
• Tongue—differentiates from other
rashes, by day 4–5 “red strawberry”
appearance
68. Scarlet Fever
• Prevention/ immunization/immunity
• Lasting immunity after having disease
• Treatment/nursing care
• Soft or liquid diet, antipyretics, analgesics,
• Comfort measures for itching rash;
• Penicillin for streptococcal Infection
• Complications
• Glomerulonephritis or rheumatic fever if untreated